Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jianchang Lin

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
Clinical Pharmacology in Drug Development|June 19, 2021
Effects of Itraconazole and Rifampin on the Pharmacokinetics of Mobocertinib (TAK-788), an Oral Epidermal Growth Factor Receptor Inhibitor, in Healthy VolunteersSteven Zhang, Shu Jin, Celina Griffin, et al.
Journal of Dentistry|October 21, 2015
The effectiveness of oral appliances for obstructive sleep apnea syndrome: A meta-analysisYafen Zhu, Hu Long, Fan Jian, et al.
Statistics in Medicine|April 10, 2024
A Bayesian platform trial design with hybrid control based on multisource exchangeability modellingWei Wei, Ondrej Blaha, Denise Esserman, et al.
American Journal of Orthodontics and Dentofacial Orthopedics : Official Publication of the American Association of Orthodontists, Its Constituent Societies, and the American Board of Orthodontics|August 2, 2017
Authors' responseYafen Zhu, Jianchang Lin, Hu Long, et al.
American Journal of Orthodontics and Dentofacial Orthopedics : Official Publication of the American Association of Orthodontists, Its Constituent Societies, and the American Board of Orthodontics|March 5, 2017
Comparison of survival time and comfort between 2 clear overlay retainers with different thicknesses: A pilot randomized controlled trialYafen Zhu, Jianchang Lin, Hu Long, et al.
Journal of Biopharmaceutical Statistics|February 16, 2024
Considerations for master protocols using external controlsJie Chen, Xiaoyun Nicole Li, Chengxing Cindy Lu, et al.
Clinical Pharmacology in Drug Development|June 12, 2021
Single-Dose Pharmacokinetics and Tolerability of the Oral Epidermal Growth Factor Receptor Inhibitor Mobocertinib (TAK-788) in Healthy Volunteers: Low-Fat Meal Effect and Relative Bioavailability of 2 Capsule ProductsSteven Zhang, Shu Jin, Celina Griffin, et al.
Annals of Translational Medicine|October 21, 2022
Current usage and challenges of master protocols-based on survey results by ASA BIOP oncology methodology working group master protocol sub-teamXiaoyun Li, Chengxing Lu, Kristine Broglio, et al.
Clinical Pharmacology and Therapeutics|April 25, 2022
Mobocertinib Dose Rationale in Patients with Metastatic NSCLC with EGFR Exon 20 Insertions: Exposure-Response Analyses of a Pivotal Phase I/II StudyNeeraj Gupta, Anna Largajolli, Han Witjes, et al.
Pharmaceutical Statistics|February 24, 2021
Principal stratum strategy: Potential role in drug developmentBjörn Bornkamp, Kaspar Rufibach, Jianchang Lin, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
Clinical Pharmacology in Drug Development|June 19, 2021
Effects of Itraconazole and Rifampin on the Pharmacokinetics of Mobocertinib (TAK-788), an Oral Epidermal Growth Factor Receptor Inhibitor, in Healthy VolunteersSteven Zhang, Shu Jin, Celina Griffin, et al.
Journal of Dentistry|October 21, 2015
The effectiveness of oral appliances for obstructive sleep apnea syndrome: A meta-analysisYafen Zhu, Hu Long, Fan Jian, et al.
Statistics in Medicine|April 10, 2024
A Bayesian platform trial design with hybrid control based on multisource exchangeability modellingWei Wei, Ondrej Blaha, Denise Esserman, et al.
American Journal of Orthodontics and Dentofacial Orthopedics : Official Publication of the American Association of Orthodontists, Its Constituent Societies, and the American Board of Orthodontics|August 2, 2017
Authors' responseYafen Zhu, Jianchang Lin, Hu Long, et al.
American Journal of Orthodontics and Dentofacial Orthopedics : Official Publication of the American Association of Orthodontists, Its Constituent Societies, and the American Board of Orthodontics|March 5, 2017
Comparison of survival time and comfort between 2 clear overlay retainers with different thicknesses: A pilot randomized controlled trialYafen Zhu, Jianchang Lin, Hu Long, et al.
Journal of Biopharmaceutical Statistics|February 16, 2024
Considerations for master protocols using external controlsJie Chen, Xiaoyun Nicole Li, Chengxing Cindy Lu, et al.
Clinical Pharmacology in Drug Development|June 12, 2021
Single-Dose Pharmacokinetics and Tolerability of the Oral Epidermal Growth Factor Receptor Inhibitor Mobocertinib (TAK-788) in Healthy Volunteers: Low-Fat Meal Effect and Relative Bioavailability of 2 Capsule ProductsSteven Zhang, Shu Jin, Celina Griffin, et al.
Annals of Translational Medicine|October 21, 2022
Current usage and challenges of master protocols-based on survey results by ASA BIOP oncology methodology working group master protocol sub-teamXiaoyun Li, Chengxing Lu, Kristine Broglio, et al.
Clinical Pharmacology and Therapeutics|April 25, 2022
Mobocertinib Dose Rationale in Patients with Metastatic NSCLC with EGFR Exon 20 Insertions: Exposure-Response Analyses of a Pivotal Phase I/II StudyNeeraj Gupta, Anna Largajolli, Han Witjes, et al.
Pharmaceutical Statistics|February 24, 2021
Principal stratum strategy: Potential role in drug developmentBjörn Bornkamp, Kaspar Rufibach, Jianchang Lin, et al.
Pageof 8